The HSF1 Knockout KYSE-30 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the human esophageal squamous cell carcinoma cell line KYSE-30. This product features targeted disruption of the HSF1 gene, which encodes the master transcriptional regulator of the heat shock response. The knockout model is generated using CRISPR/Cas9-mediated gene disruption, resulting in a heterogeneous pool of cells with loss-of-function mutations in HSF1, enabling functional studies of this critical stress-responsive transcription factor.
The KYSE-30 parental cell line was established from a well-differentiated invasive esophageal squamous cell carcinoma and serves as a widely used in vitro model of this malignancy. These cells retain key features of esophageal cancer, including oncogenic signaling pathways and stress adaptation mechanisms. HSF1 is frequently activated in esophageal squamous cell carcinoma and contributes to tumor progression by promoting proteostasis and cell survival under adverse conditions. The polyclonal knockout population provides a relevant background to dissect HSF1-dependent processes in this disease context.
HSF1 is a stress-inducible transcription factor that monitors proteostasis. Under proteotoxic stress, it is activated by heat shock, oxidative stress, and proteasome inhibition, and regulated by kinases including CK2, GSK3??, PLK1, mTOR, and ERK. Upon activation, HSF1 trimerizes, binds heat shock elements, and drives expression of chaperones and cytoprotective factors such as HSP70 (HSPA1A), HSP90 (HSP90AA1), HSP27 (HSPB1), BAG3, and HMOX1. HSF1 interacts with HSP70, HSP90, SIRT1, p300, and BRG1, and its activity is modulated by phosphorylation and SUMOylation. In cancer, HSF1 promotes malignant progression by sustaining proteostasis and suppressing apoptosis, often through survivin and MCL-1 induction.
In esophageal squamous cell carcinoma, HSF1 is often aberrantly activated and linked to enhanced cell survival, drug resistance, and metastatic potential. The polyclonal HSF1 knockout KYSE-30 cells offer a powerful loss-of-function model to investigate how HSF1 orchestrates stress adaptation and oncogenic signaling in this tumor type. By comparing the knockout population with parental controls, researchers can probe HSF1??s contribution to proteostasis maintenance, apoptosis regulation, and resistance to chemotherapeutics or HSP90 inhibitors. This model is particularly valuable for dissecting HSF1-mediated transcriptional programs and their impact on esophageal cancer cell biology.
The polyclonal HSF1 knockout KYSE-30 cells are suitable for a broad range of experimental approaches. Typical applications include heat shock response assays to assess chaperone induction, Western blotting and RT-qPCR for target gene expression analysis, ChIP-qPCR to examine HSF1 binding at heat shock elements, and cell viability or apoptosis assays under stress conditions. The model is also appropriate for RNA-seq-based transcriptomic profiling to map HSF1-dependent gene networks, co-immunoprecipitation studies to probe protein?Cprotein interactions, and drug sensitivity testing to evaluate HSP90 inhibitor efficacy. For inquiries regarding this product or additional knockout options, please contact Ascent Research.
